• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

American Cancer Society and Color Health Partner to Provide Free Lung Cancer Screening

Share:

November 20, 2023

The American Cancer Society (ACS) and Color Health have joined forces in a new initiative to offer free lung cancer screenings for eligible individuals. This program aims to simplify the eligibility process, highlight screening options, and facilitate screenings, with the overarching goal of increasing the number of Americans undergoing screening for lung cancer. Presently, fewer than 6% of eligible individuals receive annual low-dose CT scans, despite research indicating a 20% reduction in lung cancer deaths through such screenings. The initiative seeks to remove barriers like navigating healthcare systems and combating stigmas associated with lung cancer, particularly among current or former smokers. This comprehensive Lung Screening Access Program covers risk assessment, eligibility assessment, consultations, referrals, and assistance in scheduling screenings, available regardless of employer benefits or insurance coverage.

The American Cancer Society (ACS) and Color Health have announced a new program to provide free lung cancer screening access to eligible individuals.

The program will make it easy for people to determine their eligibility, identify screening options, and get screened. The goal of the program is to increase the number of eligible Americans who get screened for lung cancer, which is the leading cause of cancer death in the United States.

Impact Program to Increase Access to Lung Cancer Screening

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The program aims to increase the number of eligible individuals who get screened, as less than 6% currently undergo annual low-dose CT (ldCT) scans, despite research showing a 20% reduction in lung cancer deaths with such screenings. Individuals, irrespective of employer benefits or insurance providers, can access these services at no cost, addressing barriers like difficulty navigating the healthcare system and the stigma associated with lung cancer, especially among current or former smokers. The Lung Screening Access Program includes risk assessment, eligibility guidance, consultation, referral, and support in booking screenings.

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Can Artificial Intelligence Take the Next Step for Drug Repositioning?Can Artificial Intelligence Take the Next Step for Drug Repositioning?
  • Florence Acquires Virtual Care Solution ZipnosisFlorence Acquires Virtual Care Solution Zipnosis
  • Proteor to Expand Lower Limb Prosthetics Portfolio Through Its Acquisition of Freedom Innovations AssetsProteor to Expand Lower Limb Prosthetics Portfolio Through Its Acquisition of Freedom Innovations Assets
  • Stryker Completes Acquisition of Vocera CommunicationsStryker Completes Acquisition of Vocera Communications
  • Adding Multimedia Velan Capital Agrees to Support Merger of Lantheus and ProgenicsAdding Multimedia Velan Capital Agrees to Support Merger of Lantheus and Progenics
  • Philips, Dept. of Defense Partner to Develop AI-Algorithm to Detect Infection 48 Hours Before Observable SymptomsPhilips, Dept. of Defense Partner to Develop AI-Algorithm to Detect Infection 48 Hours Before Observable Symptoms
  • Sinopharm buys 60 pct device distributor for $765 mlnSinopharm buys 60 pct device distributor for $765 mln
  • HLTH22: Rimidi Launches New Respiratory Module to Deliver Better TreatmentHLTH22: Rimidi Launches New Respiratory Module to Deliver Better Treatment

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications